MedTrace Logo

The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout

NCT03131583 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2019-08-08

No results posted yet for this study

Summary

The objective of the study is to assess the pharmacodynamic properties of drug-drug of SHR4640, Febuxostat and Colchicine interaction in patients with gout.

Conditions

Interventions

DRUG

Colchicine

Day-14\~Day16 qd

DRUG

Febuxostat

Day1 and Day8 qd

DRUG

SHR4640

Day3\~Day8 qd

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-17
Primary Completion
2018-01-29
Completion
2018-01-29

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03131583 on ClinicalTrials.gov